Volume | 1,559,879 |
|
|||||
News | - | ||||||
Day High | 0.4848 | Low High |
|||||
Day Low | 0.441 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Northwest Biotherapeutics Inc (QB) | NWBO | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.449 | 0.441 | 0.4848 | 0.47 | 0.449 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
541 | 1,559,879 | US$ 0.456805 | US$ 712,561 | - | 0.4001 - 1.11 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
14:59:59 | 73 | US$ 0.47 | USD |
Northwest Biotherapeutics Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
202.29M | 1.10B | 972.39M | 1.93M | -64.37M | -0.05 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Northwest Biotherapeutics (QB) News
Date | Time | Source | News Article |
---|---|---|---|
3/01/2024 | 16:04 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form.. |
12/01/2023 | 19:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
11/16/2023 | 16:11 | Edgar (US Regulatory) | Form 8-K - Current report |
11/15/2023 | 06:19 | InvestorsHub NewsWire | Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to.. |
11/09/2023 | 15:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
11/09/2023 | 07:00 | InvestorsHub NewsWire | Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone.. |
11/07/2023 | 06:29 | InvestorsHub NewsWire | Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone.. |
8/09/2023 | 15:36 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NWBO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.469 | 0.4848 | 0.4376 | 0.4551839 | 1,483,822 | 0.001 | 0.21% |
1 Month | 0.55 | 0.56 | 0.4376 | 0.481397 | 1,381,210 | -0.08 | -14.55% |
3 Months | 0.554 | 0.6489 | 0.4376 | 0.5244811 | 1,586,245 | -0.084 | -15.16% |
6 Months | 0.8799 | 0.929 | 0.4376 | 0.6272756 | 1,727,024 | -0.4099 | -46.58% |
1 Year | 0.57 | 1.11 | 0.4001 | 0.6576494 | 1,847,213 | -0.10 | -17.54% |
3 Years | 1.44 | 2.15 | 0.3862 | 0.8487945 | 2,090,962 | -0.97 | -67.36% |
5 Years | 0.3479 | 2.54 | 0.005 | 0.8519128 | 2,299,008 | 0.1221 | 35.10% |
Northwest Biotherapeutics (QB) Description
Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA. |